X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (489) 489
Publication (36) 36
Patent (22) 22
Book Review (3) 3
Book Chapter (2) 2
Book / eBook (1) 1
Compact Disc (1) 1
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (186) 186
index medicus (152) 152
oncology (135) 135
male (129) 129
cancer (100) 100
middle aged (100) 100
female (92) 92
aged (80) 80
adult (65) 65
chemotherapy (54) 54
antineoplastic agents - therapeutic use (47) 47
survival (43) 43
treatment outcome (42) 42
hematology, oncology and palliative medicine (38) 38
prognosis (37) 37
tumors (37) 37
neoplasms - drug therapy (33) 33
aged, 80 and over (30) 30
life sciences (30) 30
clinical trials (29) 29
patients (29) 29
care and treatment (28) 28
prostate cancer (28) 28
risk factors (28) 28
metastasis (26) 26
young adult (25) 25
antineoplastic agents - adverse effects (24) 24
medicine & public health (24) 24
prospective studies (24) 24
urology (24) 24
immunotherapy (22) 22
medical research (21) 21
pharmacology & pharmacy (21) 21
research (21) 21
retrospective studies (21) 21
therapy (21) 21
urology & nephrology (21) 21
neoplasm metastasis (20) 20
solid tumors (20) 20
disease-free survival (19) 19
analysis (18) 18
prostatic neoplasms, castration-resistant - drug therapy (18) 18
antineoplastic combined chemotherapy protocols - therapeutic use (17) 17
docetaxel (16) 16
pharmacology/toxicology (16) 16
toxicity (16) 16
abiraterone acetate (15) 15
france (15) 15
safety (15) 15
biopsy (14) 14
dose-response relationship, drug (14) 14
management (14) 14
metastases (14) 14
neoplasms - pathology (14) 14
pharmacology (14) 14
physics (14) 14
proportional hazards models (14) 14
surgery (14) 14
survival analysis (14) 14
bevacizumab (13) 13
clinical trials as topic (13) 13
drug administration schedule (13) 13
kaplan-meier estimate (13) 13
multivariate analysis (13) 13
radiotherapy (13) 13
respiratory system (13) 13
time factors (13) 13
angiogenesis (12) 12
antineoplastic agents - administration & dosage (12) 12
carcinoma (12) 12
chemical sciences (12) 12
cisplatin (12) 12
clinical trials, phase i as topic (12) 12
complications and side effects (12) 12
disease progression (12) 12
medicine, experimental (12) 12
molecular targeted therapy (12) 12
prostate-specific antigen - blood (12) 12
studies (12) 12
angiogenesis inhibitors - adverse effects (11) 11
antimitotic agents (11) 11
antineoplastic agents (11) 11
biomarkers (11) 11
drug therapy (11) 11
lung cancer (11) 11
lung-cancer (11) 11
metastatic breast-cancer (11) 11
neoplasm staging (11) 11
predictive value of tests (11) 11
prostatic neoplasms - drug therapy (11) 11
prostatic neoplasms, castration-resistant - pathology (11) 11
protein kinase inhibitors - adverse effects (11) 11
sunitinib (11) 11
abiraterone (10) 10
adolescent (10) 10
androgen receptor (10) 10
antibodies, monoclonal - adverse effects (10) 10
carcinoma, renal cell - drug therapy (10) 10
enzalutamide (10) 10
everolimus (10) 10
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS Medicine, ISSN 1549-1277, 12/2016, Volume 13, Issue 12, pp. e1002201 - e1002201
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 04/2018, Volume 24, Issue 7, pp. 1536 - 1545
Journal Article
Bulletin du Cancer, ISSN 0007-4551, 11/2017, Volume 104, Issue 11, pp. 956 - 957
Journal Article
Journal Article
Bulletin du cancer, 11/2017, Volume 104, Issue 11, p. 956
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 9, pp. 975 - 985
Journal Article
International Journal of Colorectal Disease, ISSN 0179-1958, 1/2019, Volume 34, Issue 1, pp. 71 - 83
Postoperative ileus (POI) occurrence within enhanced recovery programs (ERPs) has decreased. Also, intra-abdominal complications (IAC) such as anastomotic... 
Postoperative ileus | Anastomotic leakage | Medicine & Public Health | Surgery | Hepatology | Gastroenterology | Internal Medicine | Colorectal surgery | Morbidity | Proctology | Inflammatory bowel diseases | Databases | Intestine | Event-related potentials | Risk factors | Age | Tumors | Abdomen | Cancer
Journal Article
Bulletin du Cancer, ISSN 0007-4551, 02/2014, Volume 101, Issue 2, p. 115
Journal Article
Bulletin du Cancer, ISSN 0007-4551, 2014, Volume 101, Issue 3, p. 223
Journal Article
Investigational New Drugs, ISSN 0167-6997, 02/2012, Volume 30, Issue 1, p. 424
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 12/2011, Volume 8, Issue 12, pp. 701 - 710
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 12/2018, Volume 15, Issue 12, pp. 748 - 762
Anti-PD-1/PD-L1 monoclonal antibodies have substantially improved the overall survival of a subset of patients across multiple solid tumour types, but other... 
BONE-SCAN | LUNG-CANCER PATIENTS | ONCOLOGY | PD-1 BLOCKADE | IFN-GAMMA | REGULATORY T-CELLS | ACQUIRED-RESISTANCE | OPEN-LABEL | SCAN FLARE PHENOMENON | TUMOR-GROWTH RATE | IMMUNE-CHECKPOINT BLOCKADE | Cell activation | Immune checkpoint | PD-1 protein | Immunoregulation | Biopsy | PD-L1 protein | Monoclonal antibodies | Lymphocytes T | Solid tumors | Patients
Journal Article
Bulletin du Cancer, ISSN 0007-4551, 06/2015, Volume 102, Issue 6, pp. 501 - 508
Therapeutic arsenal in prostate cancer widens for several years. New hormonal therapies such as acetate abiraterone or enzalutamide were the first molecules to... 
Cabozantinib | Abiraterone | MOSCATO | Enzalutamide | CRPC
Journal Article
The Lancet Oncology, ISSN 1470-2045, 09/2018, Volume 19, Issue 9, pp. 1180 - 1191
Because responses of patients with cancer to immunotherapy can vary in success, innovative predictors of response to treatment are urgently needed to improve... 
IMMUNE | MELANOMA | PEMBROLIZUMAB | ONCOLOGY | CT IMAGES | TEXTURE ANALYSIS | PATHOLOGY | CANCER | EXPRESSION | LYMPHOCYTES | Analysis | Immunotherapy | Tumors | Life Sciences | Bioengineering | Bioinformatics | Computer Science
Journal Article